Skip to main content

Advertisement

Log in

Probiotics for the prevention of Hirschsprung-associated enterocolitis: a systematic review and meta-analysis

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Background/purpose

Hirschsprung-associated enterocolitis (HAEC) is a life-threatening complication of Hirschsprung’s disease. HAEC is reported to occur in 6–50% of patients preoperatively and in 2–35% postoperatively. The exact cause of HAEC is not fully understood, but disturbances of intestinal microbiota have recently been reported in patients with HAEC. In recent years, the administration of probiotics has been proposed to reduce the incidence of HAEC. We conducted a systematic review and meta-analysis to determine the effect of probiotics on postoperative HAEC.

Methods

A systematic literature search for relevant articles was performed in four databases using the combinations of following terms “probiotics”, “microbiota”, “enterocolitis”, “Lactobacillus”, “Bifidobacterium”, “Saccharomyces”, “Streptococcus”, and “Hirschsprung disease/Hirschsprung’s disease” for studies published between 2002 and 2017. The relevant cohorts of the effect of probiotics in postoperative patients were systematically searched for clinical outcomes. Odds ratio (OR) or standard mean difference (SMD) with 95% confidence intervals (CI) were calculated using standardized statistical methodology.

Results

The search strategy identified 1274 reports. Overall, five studies met defined inclusion criteria, reporting a total of 198 patients. Two studies were prospective multicenter randomized control trials. Lactobacillus, Bifidobacterium, Streptococcus, and Enterococcus were used as probiotics. The incidence of HAEC with/without probiotics was 22.6 and 30.5%, respectively, but this was not statistically different (OR 0.72; 95% CI 0.37–1.39; P = 0.33).

Conclusion

This study shows that the administration of probiotics was not associated with a significant reduction in the risk of HAEC. Additional studies are required to understand more fully the role of microbiota and complex interactions that cause HAEC. With increasing knowledge of the role of microbiota in HAEC, we are likely to understand better the potential benefits of probiotics in this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Michail S, Abernathy F (2003) Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr 36:385–391

    Article  PubMed  Google Scholar 

  2. Michail S, Abernathy F (2002) Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 35:350–355

    Article  CAS  PubMed  Google Scholar 

  3. Salari P, Nikfar S, Abdollahi M (2012) A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets 11:3–14

    Article  CAS  PubMed  Google Scholar 

  4. Deshpande G, Rao S, Patole S, Bulsara M (2010) Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125:921–930

    Article  PubMed  Google Scholar 

  5. Holubar SD, Cima RR, Sandborn WJ, Pardi DS (2010) Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev 6:CD001176

    Google Scholar 

  6. Mattar AF, Coran AG, Teitelbaum DH (2003) MUC-2 mucin production in Hirschsprung’s disease: possible association with enterocolitis development. J Pediatr Surg 38:417–421 (discussion 417–421)

    Article  PubMed  Google Scholar 

  7. El-Sawaf M, Siddiqui S, Mahmoud M, Drongowski R, Teitelbaum DH (2013) Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg 48:111–117

    Article  PubMed  Google Scholar 

  8. Wang X, Li Z, Xu Z, Wang Z, Feng J (2015) Probiotics prevent Hirschsprung’s disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Colorectal Dis 30:105–110

    Article  PubMed  Google Scholar 

  9. Frykman PK, Nordenskjold A, Kawaguchi A, Hui TT, Granstrom AL, Cheng Z et al (2015) Characterization of bacterial and fungal microbiome in children with Hirschsprung disease with and without a history of enterocolitis: a multicenter study. PLoS One 10:e0124172

    Article  PubMed  PubMed Central  Google Scholar 

  10. Demehri FR, Frykman PK, Cheng Z, Ruan C, Wester T, Nordenskjold A et al (2016) Altered fecal short chain fatty acid composition in children with a history of Hirschsprung-associated enterocolitis. J Pediatr Surg 51:81–86

    Article  PubMed  Google Scholar 

  11. Yin Y, Wang Z, He X (2011) Clinical study on probiotics in the prevention of hirschsprung’s enterocolitis after surgery. Anhui Med J 6:5

    Google Scholar 

  12. Khan MW, Kale AA, Bere P, Vajjala S, Gounaris E, Pakanati KC (2012) Microbes, intestinal inflammation and probiotics. Expert Rev Gastroenterol Hepatol 6:81–94

    Article  PubMed  Google Scholar 

  13. Shen DH, Shi CR, Chen JJ, Yu SY, Wu Y, Yan WB (2009) Detection of intestinal bifidobacteria and lactobacilli in patients with Hirschsprung’s disease associated enterocolitis. World J Pediatr 5:201–205

    Article  CAS  PubMed  Google Scholar 

  14. Underwood MA (2017) Impact of probiotics on necrotizing enterocolitis. Semin Perinatol 41:41–51

    Article  PubMed  Google Scholar 

  15. Keita AV, Soderholm JD (2010) The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 22:718–733

    Article  CAS  PubMed  Google Scholar 

  16. Snoek SA, Verstege MI, Boeckxstaens GE, van den Wijngaard RM, de Jonge WJ (2010) The enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease. Expert Rev Gastroenterol Hepatol 4:637–651

    Article  PubMed  Google Scholar 

  17. Belet N, Dalgic N, Oncel S, Ciftci E, Ince E, Guriz H et al (2005) Catheter-related fungemia caused by Saccharomyces cerevisiae in a newborn. Pediatr Infect Dis J 24:1125

    Article  PubMed  Google Scholar 

  18. Perapoch J, Planes AM, Querol A, Lopez V, Martinez-Bendayan I, Tormo R et al (2000) Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur J Clin Microbiol Infect Dis 19:468–470

    Article  CAS  PubMed  Google Scholar 

  19. Dani C, Coviello CC, Corsini II, Arena F, Antonelli A, Rossolini GM (2016) Lactobacillus sepsis and probiotic therapy in newborns: two new cases and literature review. AJP Rep 6:e25-29

    Google Scholar 

  20. Brecht M, Garg A, Longstaff K, Cooper C, Andersen C (2016) Lactobacillus sepsis following a laparotomy in a preterm infant: a note of caution. Neonatology 109:186–189

    Article  PubMed  Google Scholar 

  21. Kunz AN, Noel JM, Fairchok MP (2004) Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 38:457–458

    Article  PubMed  Google Scholar 

  22. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115:178–181

    Article  PubMed  Google Scholar 

  23. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR (2005) Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 24:278–280

    Article  PubMed  Google Scholar 

  24. Sadowska-Krawczenko I, Paprzycka M, Korbal P, Wiatrzyk A, Krysztopa-Grzybowska K, Polak M et al (2014) Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. Benef Microbes 5:397–402

    Article  CAS  PubMed  Google Scholar 

  25. Bertelli C, Pillonel T, Torregrossa A, Prod’hom G, Fischer CJ, Greub G et al (2015) Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 60:924–927

    Article  CAS  PubMed  Google Scholar 

  26. Zbinden A, Zbinden R, Berger C, Arlettaz R (2015) Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 107:56–59

    Article  PubMed  Google Scholar 

  27. Ohishi A, Takahashi S, Ito Y, Ohishi Y, Tsukamoto K, Nanba Y et al (2010) Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr 156:679–681

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Puri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, H., Lim, T. & Puri, P. Probiotics for the prevention of Hirschsprung-associated enterocolitis: a systematic review and meta-analysis. Pediatr Surg Int 34, 189–193 (2018). https://doi.org/10.1007/s00383-017-4188-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-017-4188-y

Keywords

Navigation